The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.
D000208:Acute Disease; D019264:Adoptive Transfer; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000401:mortality*; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy*; D011237:Predictive Value of Tests; D011379:Prognosis; D016019:Survival Analysis